Header and Body 1


This invention is applicable to any research-- industrial, medical, clinical, or otherwise-- that would require high-throughput screening with the goal of finding an optically active nanoparticle that is able to recognize a specific biological molecule. It can replace macromolecule detection methods and protein assays both in vitro and in vivo, such as ELISA or lateral flow strips, immunohistochemistry, and protein-resin binding, for real-time diagnostics. It can also be used therapeutically to block receptor-ligand interactions.